nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—colon cancer—Dexamethasone—ankylosing spondylitis	0.277	0.366	CpDpCtD
Aprepitant—colon cancer—Betamethasone—ankylosing spondylitis	0.277	0.366	CpDpCtD
Aprepitant—breast cancer—Dexamethasone—ankylosing spondylitis	0.102	0.134	CpDpCtD
Aprepitant—breast cancer—Betamethasone—ankylosing spondylitis	0.102	0.134	CpDpCtD
Aprepitant—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0284	0.159	CbGbCtD
Aprepitant—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0189	0.106	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0189	0.106	CbGbCtD
Aprepitant—CYP2C19—Prednisone—ankylosing spondylitis	0.0183	0.103	CbGbCtD
Aprepitant—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0146	0.0818	CbGbCtD
Aprepitant—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0142	0.0794	CbGbCtD
Aprepitant—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0115	0.064	CbGbCtD
Aprepitant—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0111	0.062	CbGbCtD
Aprepitant—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00952	0.0532	CbGbCtD
Aprepitant—CYP3A4—Betamethasone—ankylosing spondylitis	0.00952	0.0532	CbGbCtD
Aprepitant—CYP3A4—Prednisolone—ankylosing spondylitis	0.00939	0.0525	CbGbCtD
Aprepitant—CYP3A4—Prednisone—ankylosing spondylitis	0.00887	0.0496	CbGbCtD
Aprepitant—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00554	0.0309	CbGbCtD
Aprepitant—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000101	0.00156	CcSEcCtD
Aprepitant—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000101	0.00155	CcSEcCtD
Aprepitant—Syncope—Dexamethasone—ankylosing spondylitis	0.000101	0.00155	CcSEcCtD
Aprepitant—Syncope—Betamethasone—ankylosing spondylitis	0.000101	0.00155	CcSEcCtD
Aprepitant—Infection—Triamcinolone—ankylosing spondylitis	0.000101	0.00155	CcSEcCtD
Aprepitant—Infection—Methylprednisolone—ankylosing spondylitis	0.0001	0.00154	CcSEcCtD
Aprepitant—Haematuria—Methotrexate—ankylosing spondylitis	0.0001	0.00154	CcSEcCtD
Aprepitant—Shock—Triamcinolone—ankylosing spondylitis	9.97e-05	0.00153	CcSEcCtD
Aprepitant—Insomnia—Prednisolone—ankylosing spondylitis	9.96e-05	0.00153	CcSEcCtD
Aprepitant—Alopecia—Prednisone—ankylosing spondylitis	9.96e-05	0.00153	CcSEcCtD
Aprepitant—Shock—Methylprednisolone—ankylosing spondylitis	9.94e-05	0.00153	CcSEcCtD
Aprepitant—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	9.91e-05	0.00152	CcSEcCtD
Aprepitant—Loss of consciousness—Dexamethasone—ankylosing spondylitis	9.9e-05	0.00152	CcSEcCtD
Aprepitant—Loss of consciousness—Betamethasone—ankylosing spondylitis	9.9e-05	0.00152	CcSEcCtD
Aprepitant—Paraesthesia—Prednisolone—ankylosing spondylitis	9.89e-05	0.00152	CcSEcCtD
Aprepitant—Tachycardia—Triamcinolone—ankylosing spondylitis	9.89e-05	0.00152	CcSEcCtD
Aprepitant—Mental disorder—Prednisone—ankylosing spondylitis	9.87e-05	0.00152	CcSEcCtD
Aprepitant—Tachycardia—Methylprednisolone—ankylosing spondylitis	9.87e-05	0.00152	CcSEcCtD
Aprepitant—Skin disorder—Methylprednisolone—ankylosing spondylitis	9.82e-05	0.00151	CcSEcCtD
Aprepitant—Erythema—Prednisone—ankylosing spondylitis	9.81e-05	0.00151	CcSEcCtD
Aprepitant—Malnutrition—Prednisone—ankylosing spondylitis	9.81e-05	0.00151	CcSEcCtD
Aprepitant—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	9.79e-05	0.0015	CcSEcCtD
Aprepitant—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	9.77e-05	0.0015	CcSEcCtD
Aprepitant—Convulsion—Dexamethasone—ankylosing spondylitis	9.76e-05	0.0015	CcSEcCtD
Aprepitant—Convulsion—Betamethasone—ankylosing spondylitis	9.76e-05	0.0015	CcSEcCtD
Aprepitant—Hypertension—Dexamethasone—ankylosing spondylitis	9.72e-05	0.00149	CcSEcCtD
Aprepitant—Hypertension—Betamethasone—ankylosing spondylitis	9.72e-05	0.00149	CcSEcCtD
Aprepitant—Myalgia—Dexamethasone—ankylosing spondylitis	9.59e-05	0.00147	CcSEcCtD
Aprepitant—Myalgia—Betamethasone—ankylosing spondylitis	9.59e-05	0.00147	CcSEcCtD
Aprepitant—Anxiety—Betamethasone—ankylosing spondylitis	9.56e-05	0.00147	CcSEcCtD
Aprepitant—Anxiety—Dexamethasone—ankylosing spondylitis	9.56e-05	0.00147	CcSEcCtD
Aprepitant—Discomfort—Betamethasone—ankylosing spondylitis	9.47e-05	0.00146	CcSEcCtD
Aprepitant—Discomfort—Dexamethasone—ankylosing spondylitis	9.47e-05	0.00146	CcSEcCtD
Aprepitant—Hypotension—Methylprednisolone—ankylosing spondylitis	9.45e-05	0.00145	CcSEcCtD
Aprepitant—Pain—Prednisolone—ankylosing spondylitis	9.42e-05	0.00145	CcSEcCtD
Aprepitant—Pharyngitis—Methotrexate—ankylosing spondylitis	9.35e-05	0.00144	CcSEcCtD
Aprepitant—Urinary tract disorder—Methotrexate—ankylosing spondylitis	9.3e-05	0.00143	CcSEcCtD
Aprepitant—Urethral disorder—Methotrexate—ankylosing spondylitis	9.23e-05	0.00142	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	9.23e-05	0.00142	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	9.21e-05	0.00142	CcSEcCtD
Aprepitant—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	9.19e-05	0.00141	CcSEcCtD
Aprepitant—Oedema—Dexamethasone—ankylosing spondylitis	9.19e-05	0.00141	CcSEcCtD
Aprepitant—Anaphylactic shock—Betamethasone—ankylosing spondylitis	9.19e-05	0.00141	CcSEcCtD
Aprepitant—Oedema—Betamethasone—ankylosing spondylitis	9.19e-05	0.00141	CcSEcCtD
Aprepitant—Insomnia—Triamcinolone—ankylosing spondylitis	9.16e-05	0.00141	CcSEcCtD
Aprepitant—Insomnia—Methylprednisolone—ankylosing spondylitis	9.14e-05	0.0014	CcSEcCtD
Aprepitant—Infection—Betamethasone—ankylosing spondylitis	9.13e-05	0.0014	CcSEcCtD
Aprepitant—Infection—Dexamethasone—ankylosing spondylitis	9.13e-05	0.0014	CcSEcCtD
Aprepitant—Ill-defined disorder—Prednisone—ankylosing spondylitis	9.1e-05	0.0014	CcSEcCtD
Aprepitant—Paraesthesia—Triamcinolone—ankylosing spondylitis	9.1e-05	0.0014	CcSEcCtD
Aprepitant—Feeling abnormal—Prednisolone—ankylosing spondylitis	9.08e-05	0.00139	CcSEcCtD
Aprepitant—Paraesthesia—Methylprednisolone—ankylosing spondylitis	9.08e-05	0.00139	CcSEcCtD
Aprepitant—Anaemia—Prednisone—ankylosing spondylitis	9.07e-05	0.00139	CcSEcCtD
Aprepitant—Shock—Betamethasone—ankylosing spondylitis	9.04e-05	0.00139	CcSEcCtD
Aprepitant—Shock—Dexamethasone—ankylosing spondylitis	9.04e-05	0.00139	CcSEcCtD
Aprepitant—Dyspnoea—Triamcinolone—ankylosing spondylitis	9.03e-05	0.00139	CcSEcCtD
Aprepitant—Nervous system disorder—Dexamethasone—ankylosing spondylitis	9.01e-05	0.00139	CcSEcCtD
Aprepitant—Nervous system disorder—Betamethasone—ankylosing spondylitis	9.01e-05	0.00139	CcSEcCtD
Aprepitant—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	9e-05	0.00138	CcSEcCtD
Aprepitant—Thrombocytopenia—Betamethasone—ankylosing spondylitis	9e-05	0.00138	CcSEcCtD
Aprepitant—Tachycardia—Betamethasone—ankylosing spondylitis	8.97e-05	0.00138	CcSEcCtD
Aprepitant—Tachycardia—Dexamethasone—ankylosing spondylitis	8.97e-05	0.00138	CcSEcCtD
Aprepitant—Angioedema—Prednisone—ankylosing spondylitis	8.96e-05	0.00138	CcSEcCtD
Aprepitant—Dyspepsia—Triamcinolone—ankylosing spondylitis	8.92e-05	0.00137	CcSEcCtD
Aprepitant—Erythema multiforme—Methotrexate—ankylosing spondylitis	8.9e-05	0.00137	CcSEcCtD
Aprepitant—Dyspepsia—Methylprednisolone—ankylosing spondylitis	8.9e-05	0.00137	CcSEcCtD
Aprepitant—Hyperhidrosis—Betamethasone—ankylosing spondylitis	8.89e-05	0.00137	CcSEcCtD
Aprepitant—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	8.89e-05	0.00137	CcSEcCtD
Aprepitant—Malaise—Prednisone—ankylosing spondylitis	8.85e-05	0.00136	CcSEcCtD
Aprepitant—Eye disorder—Methotrexate—ankylosing spondylitis	8.8e-05	0.00135	CcSEcCtD
Aprepitant—Syncope—Prednisone—ankylosing spondylitis	8.8e-05	0.00135	CcSEcCtD
Aprepitant—Tinnitus—Methotrexate—ankylosing spondylitis	8.78e-05	0.00135	CcSEcCtD
Aprepitant—Anorexia—Dexamethasone—ankylosing spondylitis	8.76e-05	0.00135	CcSEcCtD
Aprepitant—Anorexia—Betamethasone—ankylosing spondylitis	8.76e-05	0.00135	CcSEcCtD
Aprepitant—Urticaria—Prednisolone—ankylosing spondylitis	8.75e-05	0.00134	CcSEcCtD
Aprepitant—Cardiac disorder—Methotrexate—ankylosing spondylitis	8.74e-05	0.00134	CcSEcCtD
Aprepitant—Fatigue—Triamcinolone—ankylosing spondylitis	8.73e-05	0.00134	CcSEcCtD
Aprepitant—Fatigue—Methylprednisolone—ankylosing spondylitis	8.71e-05	0.00134	CcSEcCtD
Aprepitant—Pain—Triamcinolone—ankylosing spondylitis	8.66e-05	0.00133	CcSEcCtD
Aprepitant—Loss of consciousness—Prednisone—ankylosing spondylitis	8.62e-05	0.00132	CcSEcCtD
Aprepitant—Hypotension—Betamethasone—ankylosing spondylitis	8.59e-05	0.00132	CcSEcCtD
Aprepitant—Hypotension—Dexamethasone—ankylosing spondylitis	8.59e-05	0.00132	CcSEcCtD
Aprepitant—Angiopathy—Methotrexate—ankylosing spondylitis	8.54e-05	0.00131	CcSEcCtD
Aprepitant—Immune system disorder—Methotrexate—ankylosing spondylitis	8.51e-05	0.00131	CcSEcCtD
Aprepitant—Convulsion—Prednisone—ankylosing spondylitis	8.5e-05	0.00131	CcSEcCtD
Aprepitant—Mediastinal disorder—Methotrexate—ankylosing spondylitis	8.49e-05	0.0013	CcSEcCtD
Aprepitant—Hypertension—Prednisone—ankylosing spondylitis	8.47e-05	0.0013	CcSEcCtD
Aprepitant—Chills—Methotrexate—ankylosing spondylitis	8.45e-05	0.0013	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	8.37e-05	0.00129	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	8.37e-05	0.00129	CcSEcCtD
Aprepitant—Myalgia—Prednisone—ankylosing spondylitis	8.35e-05	0.00128	CcSEcCtD
Aprepitant—Arthralgia—Prednisone—ankylosing spondylitis	8.35e-05	0.00128	CcSEcCtD
Aprepitant—Feeling abnormal—Triamcinolone—ankylosing spondylitis	8.35e-05	0.00128	CcSEcCtD
Aprepitant—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	8.33e-05	0.00128	CcSEcCtD
Aprepitant—Anxiety—Prednisone—ankylosing spondylitis	8.32e-05	0.00128	CcSEcCtD
Aprepitant—Alopecia—Methotrexate—ankylosing spondylitis	8.32e-05	0.00128	CcSEcCtD
Aprepitant—Insomnia—Betamethasone—ankylosing spondylitis	8.31e-05	0.00128	CcSEcCtD
Aprepitant—Insomnia—Dexamethasone—ankylosing spondylitis	8.31e-05	0.00128	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	8.29e-05	0.00127	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	8.27e-05	0.00127	CcSEcCtD
Aprepitant—Paraesthesia—Betamethasone—ankylosing spondylitis	8.25e-05	0.00127	CcSEcCtD
Aprepitant—Paraesthesia—Dexamethasone—ankylosing spondylitis	8.25e-05	0.00127	CcSEcCtD
Aprepitant—Discomfort—Prednisone—ankylosing spondylitis	8.25e-05	0.00127	CcSEcCtD
Aprepitant—Mental disorder—Methotrexate—ankylosing spondylitis	8.25e-05	0.00127	CcSEcCtD
Aprepitant—Erythema—Methotrexate—ankylosing spondylitis	8.2e-05	0.00126	CcSEcCtD
Aprepitant—Malnutrition—Methotrexate—ankylosing spondylitis	8.2e-05	0.00126	CcSEcCtD
Aprepitant—Hypersensitivity—Prednisolone—ankylosing spondylitis	8.12e-05	0.00125	CcSEcCtD
Aprepitant—Dyspepsia—Betamethasone—ankylosing spondylitis	8.09e-05	0.00124	CcSEcCtD
Aprepitant—Dyspepsia—Dexamethasone—ankylosing spondylitis	8.09e-05	0.00124	CcSEcCtD
Aprepitant—Urticaria—Triamcinolone—ankylosing spondylitis	8.05e-05	0.00124	CcSEcCtD
Aprepitant—Urticaria—Methylprednisolone—ankylosing spondylitis	8.03e-05	0.00123	CcSEcCtD
Aprepitant—Dysgeusia—Methotrexate—ankylosing spondylitis	8.03e-05	0.00123	CcSEcCtD
Aprepitant—Body temperature increased—Triamcinolone—ankylosing spondylitis	8.01e-05	0.00123	CcSEcCtD
Aprepitant—Oedema—Prednisone—ankylosing spondylitis	8e-05	0.00123	CcSEcCtD
Aprepitant—Anaphylactic shock—Prednisone—ankylosing spondylitis	8e-05	0.00123	CcSEcCtD
Aprepitant—Abdominal pain—Methylprednisolone—ankylosing spondylitis	7.99e-05	0.00123	CcSEcCtD
Aprepitant—Decreased appetite—Betamethasone—ankylosing spondylitis	7.99e-05	0.00123	CcSEcCtD
Aprepitant—Decreased appetite—Dexamethasone—ankylosing spondylitis	7.99e-05	0.00123	CcSEcCtD
Aprepitant—Infection—Prednisone—ankylosing spondylitis	7.95e-05	0.00122	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	7.94e-05	0.00122	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	7.94e-05	0.00122	CcSEcCtD
Aprepitant—Back pain—Methotrexate—ankylosing spondylitis	7.93e-05	0.00122	CcSEcCtD
Aprepitant—Fatigue—Dexamethasone—ankylosing spondylitis	7.92e-05	0.00122	CcSEcCtD
Aprepitant—Fatigue—Betamethasone—ankylosing spondylitis	7.92e-05	0.00122	CcSEcCtD
Aprepitant—Shock—Prednisone—ankylosing spondylitis	7.88e-05	0.00121	CcSEcCtD
Aprepitant—Pain—Dexamethasone—ankylosing spondylitis	7.86e-05	0.00121	CcSEcCtD
Aprepitant—Pain—Betamethasone—ankylosing spondylitis	7.86e-05	0.00121	CcSEcCtD
Aprepitant—Nervous system disorder—Prednisone—ankylosing spondylitis	7.85e-05	0.00121	CcSEcCtD
Aprepitant—Tachycardia—Prednisone—ankylosing spondylitis	7.81e-05	0.0012	CcSEcCtD
Aprepitant—Skin disorder—Prednisone—ankylosing spondylitis	7.78e-05	0.00119	CcSEcCtD
Aprepitant—Hyperhidrosis—Prednisone—ankylosing spondylitis	7.74e-05	0.00119	CcSEcCtD
Aprepitant—Anorexia—Prednisone—ankylosing spondylitis	7.63e-05	0.00117	CcSEcCtD
Aprepitant—Ill-defined disorder—Methotrexate—ankylosing spondylitis	7.61e-05	0.00117	CcSEcCtD
Aprepitant—Anaemia—Methotrexate—ankylosing spondylitis	7.58e-05	0.00116	CcSEcCtD
Aprepitant—Feeling abnormal—Dexamethasone—ankylosing spondylitis	7.57e-05	0.00116	CcSEcCtD
Aprepitant—Feeling abnormal—Betamethasone—ankylosing spondylitis	7.57e-05	0.00116	CcSEcCtD
Aprepitant—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	7.52e-05	0.00116	CcSEcCtD
Aprepitant—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	7.52e-05	0.00116	CcSEcCtD
Aprepitant—Hypersensitivity—Triamcinolone—ankylosing spondylitis	7.46e-05	0.00115	CcSEcCtD
Aprepitant—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	7.45e-05	0.00114	CcSEcCtD
Aprepitant—Malaise—Methotrexate—ankylosing spondylitis	7.39e-05	0.00114	CcSEcCtD
Aprepitant—Urticaria—Dexamethasone—ankylosing spondylitis	7.3e-05	0.00112	CcSEcCtD
Aprepitant—Urticaria—Betamethasone—ankylosing spondylitis	7.3e-05	0.00112	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	7.29e-05	0.00112	CcSEcCtD
Aprepitant—Dizziness—Prednisolone—ankylosing spondylitis	7.28e-05	0.00112	CcSEcCtD
Aprepitant—Asthenia—Triamcinolone—ankylosing spondylitis	7.27e-05	0.00112	CcSEcCtD
Aprepitant—Abdominal pain—Betamethasone—ankylosing spondylitis	7.27e-05	0.00112	CcSEcCtD
Aprepitant—Body temperature increased—Dexamethasone—ankylosing spondylitis	7.27e-05	0.00112	CcSEcCtD
Aprepitant—Body temperature increased—Betamethasone—ankylosing spondylitis	7.27e-05	0.00112	CcSEcCtD
Aprepitant—Abdominal pain—Dexamethasone—ankylosing spondylitis	7.27e-05	0.00112	CcSEcCtD
Aprepitant—Asthenia—Methylprednisolone—ankylosing spondylitis	7.25e-05	0.00111	CcSEcCtD
Aprepitant—Insomnia—Prednisone—ankylosing spondylitis	7.24e-05	0.00111	CcSEcCtD
Aprepitant—Paraesthesia—Prednisone—ankylosing spondylitis	7.19e-05	0.0011	CcSEcCtD
Aprepitant—Pruritus—Triamcinolone—ankylosing spondylitis	7.17e-05	0.0011	CcSEcCtD
Aprepitant—Cough—Methotrexate—ankylosing spondylitis	7.15e-05	0.0011	CcSEcCtD
Aprepitant—Pruritus—Methylprednisolone—ankylosing spondylitis	7.15e-05	0.0011	CcSEcCtD
Aprepitant—Convulsion—Methotrexate—ankylosing spondylitis	7.1e-05	0.00109	CcSEcCtD
Aprepitant—Dyspepsia—Prednisone—ankylosing spondylitis	7.05e-05	0.00108	CcSEcCtD
Aprepitant—Arthralgia—Methotrexate—ankylosing spondylitis	6.98e-05	0.00107	CcSEcCtD
Aprepitant—Chest pain—Methotrexate—ankylosing spondylitis	6.98e-05	0.00107	CcSEcCtD
Aprepitant—Myalgia—Methotrexate—ankylosing spondylitis	6.98e-05	0.00107	CcSEcCtD
Aprepitant—Decreased appetite—Prednisone—ankylosing spondylitis	6.96e-05	0.00107	CcSEcCtD
Aprepitant—Rash—Prednisolone—ankylosing spondylitis	6.95e-05	0.00107	CcSEcCtD
Aprepitant—Dermatitis—Prednisolone—ankylosing spondylitis	6.94e-05	0.00107	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	6.93e-05	0.00107	CcSEcCtD
Aprepitant—Diarrhoea—Methylprednisolone—ankylosing spondylitis	6.92e-05	0.00106	CcSEcCtD
Aprepitant—Fatigue—Prednisone—ankylosing spondylitis	6.9e-05	0.00106	CcSEcCtD
Aprepitant—Headache—Prednisolone—ankylosing spondylitis	6.9e-05	0.00106	CcSEcCtD
Aprepitant—Discomfort—Methotrexate—ankylosing spondylitis	6.9e-05	0.00106	CcSEcCtD
Aprepitant—Constipation—Prednisone—ankylosing spondylitis	6.85e-05	0.00105	CcSEcCtD
Aprepitant—Confusional state—Methotrexate—ankylosing spondylitis	6.75e-05	0.00104	CcSEcCtD
Aprepitant—Dizziness—Triamcinolone—ankylosing spondylitis	6.7e-05	0.00103	CcSEcCtD
Aprepitant—Anaphylactic shock—Methotrexate—ankylosing spondylitis	6.69e-05	0.00103	CcSEcCtD
Aprepitant—Dizziness—Methylprednisolone—ankylosing spondylitis	6.68e-05	0.00103	CcSEcCtD
Aprepitant—Infection—Methotrexate—ankylosing spondylitis	6.65e-05	0.00102	CcSEcCtD
Aprepitant—Feeling abnormal—Prednisone—ankylosing spondylitis	6.6e-05	0.00101	CcSEcCtD
Aprepitant—Asthenia—Dexamethasone—ankylosing spondylitis	6.59e-05	0.00101	CcSEcCtD
Aprepitant—Asthenia—Betamethasone—ankylosing spondylitis	6.59e-05	0.00101	CcSEcCtD
Aprepitant—Nervous system disorder—Methotrexate—ankylosing spondylitis	6.56e-05	0.00101	CcSEcCtD
Aprepitant—Thrombocytopenia—Methotrexate—ankylosing spondylitis	6.55e-05	0.00101	CcSEcCtD
Aprepitant—Gastrointestinal pain—Prednisone—ankylosing spondylitis	6.55e-05	0.00101	CcSEcCtD
Aprepitant—Nausea—Prednisolone—ankylosing spondylitis	6.54e-05	0.00101	CcSEcCtD
Aprepitant—Pruritus—Dexamethasone—ankylosing spondylitis	6.5e-05	0.000999	CcSEcCtD
Aprepitant—Pruritus—Betamethasone—ankylosing spondylitis	6.5e-05	0.000999	CcSEcCtD
Aprepitant—Skin disorder—Methotrexate—ankylosing spondylitis	6.5e-05	0.000999	CcSEcCtD
Aprepitant—Hyperhidrosis—Methotrexate—ankylosing spondylitis	6.47e-05	0.000994	CcSEcCtD
Aprepitant—Vomiting—Triamcinolone—ankylosing spondylitis	6.44e-05	0.00099	CcSEcCtD
Aprepitant—Vomiting—Methylprednisolone—ankylosing spondylitis	6.43e-05	0.000988	CcSEcCtD
Aprepitant—Rash—Triamcinolone—ankylosing spondylitis	6.39e-05	0.000982	CcSEcCtD
Aprepitant—Dermatitis—Triamcinolone—ankylosing spondylitis	6.38e-05	0.000981	CcSEcCtD
Aprepitant—Anorexia—Methotrexate—ankylosing spondylitis	6.38e-05	0.00098	CcSEcCtD
Aprepitant—Rash—Methylprednisolone—ankylosing spondylitis	6.37e-05	0.000979	CcSEcCtD
Aprepitant—Dermatitis—Methylprednisolone—ankylosing spondylitis	6.37e-05	0.000978	CcSEcCtD
Aprepitant—Urticaria—Prednisone—ankylosing spondylitis	6.36e-05	0.000977	CcSEcCtD
Aprepitant—Headache—Triamcinolone—ankylosing spondylitis	6.35e-05	0.000975	CcSEcCtD
Aprepitant—Headache—Methylprednisolone—ankylosing spondylitis	6.33e-05	0.000973	CcSEcCtD
Aprepitant—Body temperature increased—Prednisone—ankylosing spondylitis	6.33e-05	0.000972	CcSEcCtD
Aprepitant—Abdominal pain—Prednisone—ankylosing spondylitis	6.33e-05	0.000972	CcSEcCtD
Aprepitant—Diarrhoea—Betamethasone—ankylosing spondylitis	6.29e-05	0.000966	CcSEcCtD
Aprepitant—Diarrhoea—Dexamethasone—ankylosing spondylitis	6.29e-05	0.000966	CcSEcCtD
Aprepitant—Hypotension—Methotrexate—ankylosing spondylitis	6.25e-05	0.000961	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	6.1e-05	0.000937	CcSEcCtD
Aprepitant—Dizziness—Betamethasone—ankylosing spondylitis	6.08e-05	0.000934	CcSEcCtD
Aprepitant—Dizziness—Dexamethasone—ankylosing spondylitis	6.08e-05	0.000934	CcSEcCtD
Aprepitant—Insomnia—Methotrexate—ankylosing spondylitis	6.05e-05	0.00093	CcSEcCtD
Aprepitant—Nausea—Triamcinolone—ankylosing spondylitis	6.02e-05	0.000925	CcSEcCtD
Aprepitant—Paraesthesia—Methotrexate—ankylosing spondylitis	6.01e-05	0.000923	CcSEcCtD
Aprepitant—Nausea—Methylprednisolone—ankylosing spondylitis	6e-05	0.000923	CcSEcCtD
Aprepitant—Dyspnoea—Methotrexate—ankylosing spondylitis	5.96e-05	0.000917	CcSEcCtD
Aprepitant—Somnolence—Methotrexate—ankylosing spondylitis	5.95e-05	0.000914	CcSEcCtD
Aprepitant—Hypersensitivity—Prednisone—ankylosing spondylitis	5.9e-05	0.000906	CcSEcCtD
Aprepitant—Dyspepsia—Methotrexate—ankylosing spondylitis	5.89e-05	0.000905	CcSEcCtD
Aprepitant—Vomiting—Dexamethasone—ankylosing spondylitis	5.84e-05	0.000898	CcSEcCtD
Aprepitant—Vomiting—Betamethasone—ankylosing spondylitis	5.84e-05	0.000898	CcSEcCtD
Aprepitant—Decreased appetite—Methotrexate—ankylosing spondylitis	5.82e-05	0.000894	CcSEcCtD
Aprepitant—Rash—Dexamethasone—ankylosing spondylitis	5.8e-05	0.000891	CcSEcCtD
Aprepitant—Rash—Betamethasone—ankylosing spondylitis	5.8e-05	0.000891	CcSEcCtD
Aprepitant—Dermatitis—Dexamethasone—ankylosing spondylitis	5.79e-05	0.00089	CcSEcCtD
Aprepitant—Dermatitis—Betamethasone—ankylosing spondylitis	5.79e-05	0.00089	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	5.78e-05	0.000888	CcSEcCtD
Aprepitant—Fatigue—Methotrexate—ankylosing spondylitis	5.77e-05	0.000886	CcSEcCtD
Aprepitant—Headache—Betamethasone—ankylosing spondylitis	5.76e-05	0.000885	CcSEcCtD
Aprepitant—Headache—Dexamethasone—ankylosing spondylitis	5.76e-05	0.000885	CcSEcCtD
Aprepitant—Asthenia—Prednisone—ankylosing spondylitis	5.74e-05	0.000883	CcSEcCtD
Aprepitant—Pain—Methotrexate—ankylosing spondylitis	5.72e-05	0.000879	CcSEcCtD
Aprepitant—Pruritus—Prednisone—ankylosing spondylitis	5.66e-05	0.00087	CcSEcCtD
Aprepitant—Feeling abnormal—Methotrexate—ankylosing spondylitis	5.51e-05	0.000847	CcSEcCtD
Aprepitant—Diarrhoea—Prednisone—ankylosing spondylitis	5.48e-05	0.000842	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	5.47e-05	0.000841	CcSEcCtD
Aprepitant—Nausea—Dexamethasone—ankylosing spondylitis	5.46e-05	0.000839	CcSEcCtD
Aprepitant—Nausea—Betamethasone—ankylosing spondylitis	5.46e-05	0.000839	CcSEcCtD
Aprepitant—Urticaria—Methotrexate—ankylosing spondylitis	5.31e-05	0.000817	CcSEcCtD
Aprepitant—Dizziness—Prednisone—ankylosing spondylitis	5.29e-05	0.000813	CcSEcCtD
Aprepitant—Abdominal pain—Methotrexate—ankylosing spondylitis	5.29e-05	0.000813	CcSEcCtD
Aprepitant—Body temperature increased—Methotrexate—ankylosing spondylitis	5.29e-05	0.000813	CcSEcCtD
Aprepitant—Vomiting—Prednisone—ankylosing spondylitis	5.09e-05	0.000782	CcSEcCtD
Aprepitant—Rash—Prednisone—ankylosing spondylitis	5.05e-05	0.000776	CcSEcCtD
Aprepitant—Dermatitis—Prednisone—ankylosing spondylitis	5.04e-05	0.000775	CcSEcCtD
Aprepitant—Headache—Prednisone—ankylosing spondylitis	5.01e-05	0.000771	CcSEcCtD
Aprepitant—Hypersensitivity—Methotrexate—ankylosing spondylitis	4.93e-05	0.000757	CcSEcCtD
Aprepitant—Asthenia—Methotrexate—ankylosing spondylitis	4.8e-05	0.000738	CcSEcCtD
Aprepitant—Nausea—Prednisone—ankylosing spondylitis	4.75e-05	0.000731	CcSEcCtD
Aprepitant—Pruritus—Methotrexate—ankylosing spondylitis	4.73e-05	0.000727	CcSEcCtD
Aprepitant—Diarrhoea—Methotrexate—ankylosing spondylitis	4.58e-05	0.000703	CcSEcCtD
Aprepitant—Dizziness—Methotrexate—ankylosing spondylitis	4.42e-05	0.00068	CcSEcCtD
Aprepitant—Vomiting—Methotrexate—ankylosing spondylitis	4.25e-05	0.000654	CcSEcCtD
Aprepitant—Rash—Methotrexate—ankylosing spondylitis	4.22e-05	0.000648	CcSEcCtD
Aprepitant—Dermatitis—Methotrexate—ankylosing spondylitis	4.21e-05	0.000648	CcSEcCtD
Aprepitant—Headache—Methotrexate—ankylosing spondylitis	4.19e-05	0.000644	CcSEcCtD
Aprepitant—Nausea—Methotrexate—ankylosing spondylitis	3.97e-05	0.000611	CcSEcCtD
